Search of: "Talaporfin" - List Results

Found 10 studies with search of:

"Talaporfin"

Hide studies that are not seeking new volunteers.

Display Options

Rank

Status

Study

1

Active, not recruiting

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Conditions:	Carcinoma, Hepatocellular; Liver Neoplasms
Interventions:	Drug: Talaporfin sodium; Device: Interstitial Light Emitting Diodes; Procedure: Percutaneous placement of device in the liver; Procedure: Standard Care

2

Recruiting

Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Conditions:	Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
Interventions:	Drug: Talaporfin sodium; Procedure: Placement of device in prostate urethra; Device: Transurethral illumination with light emitting diodes (Litx™ BPH Device)

3

Completed

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases

Conditions:	Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis
Interventions:	Drug: Talaporfin sodium (LS11); Device: LED-based light infusion device; Device: Light emitting diodes (LED); Procedure: Photodynamic therapy; Procedure: Phototherapy; Procedure: Chemotherapy

4

Terminated

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Conditions:	Macular Degeneration; Choroidal Neovascularization
Intervention:	Drug: Talaporfin Sodium (LS11) Photodynamic Therapy (PDT)

5

Completed

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Conditions:	Carcinoma, Hepatocellular; Liver Neoplasms
Interventions:	Procedure: Photodynamic therapy; Drug: Talaporfin Sodium

6

Recruiting

Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas

Condition:	Neurofibroma
Intervention:	Drug: LS11

7

Completed

Phase IIa Safety and Light Dose-Escalation Study in Patients With Primary or Recurrent/High-Grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Conditions:	Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma
Interventions:	Drug: LS11 (talaporfin sodium); Device: Light source (interstitial light emitting diodes); Procedure: Intraoperative placement of device in glioma

8

Recruiting

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Conditions:	Liver Metastases; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local
Interventions:	Drug: Talaporfin sodium; Procedure: Percutaneous placement of device in liver metastases; Device: Interstitial light emitting diodes; Drug: FOLFOX4 OR FOLFIRI regimen

9

Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Conditions:	Liver Metastasis; Pelvic Cancer; Head and Neck Cancer; Sarcoma; Rectal Cancer; Breast Cancer; Colorectal Cancer; Mouth Cancer
Interventions:	Drug: LS 11(Taporfin Sodium); Device: Lumaflex Light Delivery Catheter

10

Completed

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Conditions:	Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis
Interventions:	Drug: Talaporfin sodium (LS11); Device: LED-based light infusion device; Device: Light emitting diodes (LED); Procedure: Photodynamic therapy; Procedure: Phototherapy; Procedure: Chemotherapy

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.

RSS Feed for studies found by your search that were received in the last 14 days

Download Options